SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (250)6/26/2002 10:56:19 AM
From: Czechsinthemail  Read Replies (1) of 598
 
Nice to see TLRK refraining from the bloodletting. It has been relatively strong recently and holding up fairly well in fairly weak market environments. Perhaps investors are getting nostalgic for good old fashioned drug trial risk as an alternative to major accounting fraud.

As far as the increased short position is concerned, I hope the shorts haven't been covering yet. It will give us something to look forward to down the road.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News